ArticleBMC chemistry2025
Hydrolytic stress degradation study and concomitant HPTLC estimation of thioctic acid and biotin in their combined capsules: greenness, blueness and whiteness assessment.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stability testing and quality control assessment of active substances in single-pill combinations represent real challenges to drug analysts. This analytical challenge becomes more difficult when these drugs are non-chromophoric and co-formulated in disparate concentration ratio with few or no analytical methods reported in the literature for their concurrent quantification. This study deals with the development of HPTLC method for stability testing of hydrolytic degradation and simultaneous estimation of TH and BO in pure form, fresh and expired combined capsules. HPTLC separation was achieved using aluminium HPTLC plates precoated with silica gel 60 F-254 and mobile phase consisting of chloroform: methanol: ammonia (8.5:1.5:0.05, by volume). Scanning was performed at 215 nm. The designed method was validated as per the ICH guidelines. Excellent linearity was proved by high values of correlation coefficient not less than 0.99976 over concentration ranges of 2.5-30 and 2.5-20 µg/band for TH and BO, respectively. The limits of dectection were 0.58 and 0.33 µg/band while the limits of quantitation were 1.74 and 0.99 µg/band for TH and BO, respectively. The method proved to be precise, accurate and robust with values of RSD% and Er% not exceeding 2%. The designed method was found selective for the simultaneous estimation of BO and TH in pure form, in the presence of their degradation products, in valid and expired combined capsules. Both drugs were subjected to wet heat, acidic and basic hydrolysis. Both drugs were found liable to degradation (11-19%) under acidic (2.5 M HCl at room temperature for 30 min) and alkaline (3 M NaOH at room temperature for 30 min) hydrolytic conditions but they were found more stable under neutral hydrolytic conditions. Furthermore, Degradation kinetic study was accomplished to better understand the kinetics of their degradation under the employed stress conditions. Moreover, a tri-faceted assessment of the method's degree of greenness (Eco-Scale score is 80, AGREE score is 0.72 and MoGAPI score is 76), blueness (BAGI score is 82.5) and whiteness (score is 92.2%) was performed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.